Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation Therapy [clinicaltrials:NCT02023008]

Bio2RDF uri

Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation Therapy [clinicaltrials:NCT02023008]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT02023008

Bio2RDF identifier

NCT02023008

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT02023008

http://www.w3.org/2001/XMLSchema#string

brief summary [clinicaltrials_vocabulary:brief-summary]

This pilot clinical tri ...... oing radiation therapy.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Interactive Gentle Yoga in Imp ...... r Undergoing Radiation Therapy

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Recruitment rates, calculated as the number of women enrolled divided by the number of women who screened eligible for the study Up to week 7 [clinicaltrials_resource:0cfbad16e24179ae2c350994787f9254]

Recruitment rates, calculated as the number of women enrolled divided by the number of women who screened eligible for the study Up to week 7 [clinicaltrials_resource:2efd421cb39db9d75ea0962633b0c18c]

Recruitment rates, calculated as the number of women enrolled divided by the number of women who screened eligible for the study Up to week 7 [clinicaltrials_resource:97f74d059d439fd0d07129854a2296b9]

Recruitment rates, calculated as the number of women enrolled divided by the number of women who screened eligible for the study Up to week 7 [clinicaltrials_resource:de073b89b6ce6b43121e0434f7eba2f3]

Recruitment rates, calculated as the number of women enrolled divided by the number of women who screened eligible for the study Up to week 7 [clinicaltrials_resource:e34c35ff7e2cb0a251796843dad76e70]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Recruitment rates, calculated as the number of women enrolled divided by the number of women who screened eligible for the study Up to week 7 [clinicaltrials_resource:ad82dd5ca6a8c62f023acddb7dbf9b6d]

Recruitment rates, calculated as the number of women enrolled divided by the number of women who screened eligible for the study Up to week 7 [clinicaltrials_resource:b8da68803f0b40f85644c6c880b79926]

Recruitment rates, calculated as the number of women enrolled divided by the number of women who screened eligible for the study Up to week 7 [clinicaltrials_resource:f0c54b4d48797c62f5e8cbbfcbcd968a]

Recruitment rates, calculated as the number of women enrolled divided by the number of women who screened eligible for the study Up to week 7 [clinicaltrials_resource:f23137df1ba991f3f3a0107936a352bd]

collaborator [clinicaltrials_vocabulary:collaborator]

Comprehensive Cancer Center of Wake Forest University [clinicaltrials_resource:de0a5e905bc181e21769af9fdf4a1763]

condition [clinicaltrials_vocabulary:condition]

Stage IB Breast Cancer [clinicaltrials_resource:1d6ccb88a891a4a90f5c42f3b19e84ca]

Depression [clinicaltrials_resource:75cde58f0e5563f287f2d4afb0ce4b7e]

Stage IIIC Breast Cancer [clinicaltrials_resource:92dc3a8b46a0fe854a2f1eeb52d3aba9]

Stage IIIA Breast Cancer [clinicaltrials_resource:ab245952e70651d7345aed40074c8e22]

Fatigue [clinicaltrials_resource:b5ff1b2957e6726d30b6973aa513cb0c]

Stage II Breast Cancer [clinicaltrials_resource:c28969a2830d3f9d19ba0c33bd5ddab5]

Stage IA Breast Cancer [clinicaltrials_resource:cdf8c2ebe3e5aad21acfeb98e83db642]

Stage IIIB Breast Cancer [clinicaltrials_resource:d1aa5547dad5c027ddc64788a7af25a4]

Anxiety Disorder [clinicaltrials_resource:d8047c08725c94b6e0e388b330bbbd20]

Ductal Breast Carcinoma in Situ [clinicaltrials_resource:ff2bce3a3d9ca1ad9d03c20ae34fc074]

condition browse [clinicaltrials_vocabulary:condition-browse]

Anxiety Disorders [clinicaltrials_resource:032e33c2c1e085916b9f9dd2ad112341]

Carcinoma, Intraductal, Noninfiltrating [clinicaltrials_resource:03493d6c8cc72135aabd7f4ac231f86b]

Carcinoma in Situ [clinicaltrials_resource:b1034fcf7bc4b6129b6d2e1aaf5517ed]

Breast Neoplasms [clinicaltrials_resource:fd46a662c92164802f60e654a768351f]

Carcinoma, Ductal, Breast [clinicaltrials_resource:fe7ce85d65b6bb82f62f7b2f4e9fe378]

condition mesh [clinicaltrials_vocabulary:condition-mesh]

Anxiety Disorders [clinicaltrials_resource:032e33c2c1e085916b9f9dd2ad112341]

Carcinoma, Intraductal, Noninfiltrating [clinicaltrials_resource:03493d6c8cc72135aabd7f4ac231f86b]

Carcinoma in Situ [clinicaltrials_resource:b1034fcf7bc4b6129b6d2e1aaf5517ed]

Breast Neoplasms [clinicaltrials_resource:fd46a662c92164802f60e654a768351f]

Carcinoma, Ductal, Breast [clinicaltrials_resource:fe7ce85d65b6bb82f62f7b2f4e9fe378]

country [clinicaltrials_vocabulary:country]

United States [clinicaltrials_resource:f253efe302d32ab264a76e0ce65be769]

detailed description [clinicaltrials_vocabulary:detailed-description]

PRIMARY OBJECTIVES: ...... ts are followed up at 1 week.

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT02023008 [clinicaltrials_resource:9cef7acb27355ad14bd33ac952b10bd3]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2013-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

internet-based intervention [clinicaltrials_resource:be12abef2193bc22c01ce5876cfc625f]

yoga therapy [clinicaltrials_resource:cc4160033d13e9baf0c6fe1a2d80ae01]

questionnaire administration [clinicaltrials_resource:f0d325c3616a0b8fefdd510e3439ebf2]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2015-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Comprehensive Cancer Center of Wake Forest University [clinicaltrials_resource:de0a5e905bc181e21769af9fdf4a1763]

location [clinicaltrials_vocabulary:location]

Comprehensive Cancer Center of Wake Forest University [clinicaltrials_resource:baeb06dd08d4a680a2e7cc0f9217bb17]

nct id [clinicaltrials_vocabulary:nct-id]

NCT02023008

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

Convenient and Live Movement ( ...... a for Women With Breast Cancer

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

CCCWFU 01513

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

Suzanne Danhauer [clinicaltrials_resource:3e89dd0a672f5e067b70bc1950a9a15a]

overall status [clinicaltrials_vocabulary:overall-status]

Terminated [clinicaltrials_resource:fba9c4daa2dd29d1077d32d965320ac1]

oversight [clinicaltrials_vocabulary:oversight]

United States: Institutional Review Board [clinicaltrials_resource:b46c5f1ee626ee51e33e6c048a7b19f6]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:dbd41868ee618d3e64daa1adf8c3a8a0]

secondary id [clinicaltrials_vocabulary:secondary-id]

NCI-2013-02387

http://www.w3.org/2001/XMLSchema#string

source [clinicaltrials_vocabulary:source]

Comprehensive Cancer Center of Wake Forest University [clinicaltrials_resource:de0a5e905bc181e21769af9fdf4a1763]

start date [clinicaltrials_vocabulary:start-date]

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT02023008 study design [clinicaltrials_resource:15358d00d59d1ee6a4eec0f3f9b8e25c]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT02023008

verification date [clinicaltrials_vocabulary:verification-date]

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

why stopped [clinicaltrials_vocabulary:why-stopped]

Study is not feasible

http://www.w3.org/2001/XMLSchema#string

identifier

clinicaltrials:NCT02023008

http://www.w3.org/2001/XMLSchema#string

title

Interactive Gentle Yoga in Imp ...... r Undergoing Radiation Therapy

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

Interactive Gentle Yoga in Imp ...... y [clinicaltrials:NCT02023008]

@en